Dr. Graber is an expert in cell regulatory mechanisms that determine when and where an RNA is translated into protein; processes that often break-down in the context of cancer or neurodevelopmental disorders. His pandemic pivot has led to an alternative path of discovery, developing new methods to track human pathogens and immune correlates through wastewater.
Other Area of Research: Wastewater-based epidemiology
Near real-time determination of B. 1.1. 7 in proportion to total SARS-CoV-2 viral load in wastewater using an allele-specific primer extension PCR strategy
Our study demonstrates that this strategy can provide public health units with an additional and much needed tool to rapidly triangulate VOC incidence/prevalence with high sensitivity and lineage specificity.
The role of wastewater testing for SARS-CoV-2 surveillance
These characteristics of SARS-CoV-2 infection, along with the observation that SARSCoV-2 is excreted in stools during all phases of infection, has led to the uptake of wastewater testing to complement SARS-CoV-2 surveillance based on clinical tests and case identification.
Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence
Can we find COVID-19 markers in the wastewater that will help predict outbreaks?